Discussion 1) The study by Tukhovskaya et al investigated the impact of intranasal DSIP on motor function recovery and brain infarction volume in SD rats subjected to focal stroke induced by MCAO
[DOI] [PMC free article] [PubMed] [Google Scholar] 105.Wise R.A., Holbrook J.T., Criner G., Sethi S., Rayapudi S., Sudini K.R., Sugar E.A., Burke A., Thimmulappa R., Singh A., et al
doi: 10.1111/dom.13222
compounding pharmacies, not from overseas research chemical suppliers
Brain Health and Neurological Benefits Exciting research shows that GLP-1 medications may have impressive effects on brain health: They reduce the risk of Alzheimers disease and dementia They help protect against Parkinsons disease They lower the risk of seizures They may reduce stroke risk and improve recovery after stroke They show benefits for Huntingtons disease in early studies A January 2025 study from Washington University found that people taking GLP-1 medications had a decreased risk of neurocognitive disorders like Alzheimers